Skip to main content
. 2023 Mar 1;16:813–822. doi: 10.2147/IJGM.S399812

Table 1.

Univariate Comparison Between the GBPs and Control Groups

Overall (n=297) GBPs Group (n=60) Control Group (n=237) P-value
Age 55.97±11.10 54.85±10.44 56.26±11.26 0.381
Gender 0.002
 Male 179(60.3) 46(76.7) 133(56.1)
 Female 118(39.7) 14(23.3) 104(43.9)
BMI (kg/m2) 23.97±3.20 25.35±2.97 23.62±3.17 <0.001
Smoking 64(21.5) 15(23.4) 49(20.7) 0.468
Alcohol 120(40.4) 27(45.0) 93(39.2) 0.418
SBP (mmHg) 127.42±12.40 130.38±12.05 126.68±12.40 0.038
DBP (mmHg) 75.05±9.56 77.68±8.64 74.38±9.68 0.017
Fatty liver 96(32.3) 34(56.6) 62(26.1) <0.001
Gallstone diseases 25 (8.4) 5(8.4) 20(8.4) 0.979
Diabetes 45 (15.1) 12 (20.0) 33 (13.9) 0.241
MS 44(14.8) 14(23.3) 30(12.7) 0.038
SIBO-positive 103(34.6) 30(50.0) 73(30.8) 0.005
FG (mmol/L) 5.23±0.71 5.43±0.78 5.18±0.68 0.021
HDL-C (mmol/L) 1.32±0.33 1.23±0.25 1.34±0.34 0.003
LDL-C (mmol/L) 2.87±0.81 3.00±0.80 2.84±0.81 0.167
TG (mmol/L) 1.77±1.97 1.90±1.66 1.73±2.05 0.551
TC (mmol/L) 4.87±1.13 4.98±1.21 4.84±1.16 0.387
TBA (μmmol/L) 5.05±4.62 4.69±3.24 5.14±4.91 0.509
ALB (g/L) 40.46±3.23 41.10±3.02 40.29±3.27 0.084
ALT (U/L) 22.00±16.00 24.32±11.37 21.41±16.93 0.209
AST (U/L) 21.31±7.59 22.35±7.36 21.05±7.64 0.233
ALP (U/L) 78.12±25.63 74.87±21.84 78.84±26.48 0.272
DBIL (μmmol/L) 2.73±1.07 2.73±0.81 2.73±1.13 0.987
TBIL (μmmol/L) 12.20±6.01 12.69±4.43 12.08±6.36 0.486
γ-GT (U/L) 30.92±35.43 38.33±30.11 28.95±36.53 0.068

Abbreviations: BMI, body mass index; SIBO, small intestinal bacterial overgrowth; SBP, systolic blood pressure; DBP, diastolic blood pressure; MS, metabolic syndrome; FG, fasting glucose; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; TC, total cholesterol; TBA, total bile acids; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; DBIL, direct bilirubin; TBIL, total bilirubin; γ-GT, γ-glutamyl transpeptidase.